VC Funding in Life Sciences Plummets in Q2, Report Finds | GenomeWeb

NEW YORK (GenomeWeb News) – Venture capital investments into the life sciences dropped sharply in the second quarter compared to a year ago, according to a report this week from PricewaterhouseCoopers and the National Venture Capital Association.

VC funding into the life sciences sector, which includes biotechnology and medical devices, was down 39 percent year over year in dollar amounts and down 22 percent in the number of deals. A total of $1.4 billion was invested into 174 life science deals in the second quarter, the report said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.